Observational study of the use of recombinant tissue-type plasminogen activator in COVID-19 shows a decrease in physiological dead space
- Resource Type
- Journal
- Source
ERJ OPEN RESEARCH ; OCT 1 2020, 6 4, p00455-2020 4p.- Subject
- Language
- English
- ISSN
- 23120541